nintedanib

Boehringer Ingelheim preps FDA submission with new data in rare pediatric lung disease
Endpoints
Tue, 09/6/22 - 05:00 pm
Boehringer Ingelheim
nintedanib
Ofev
Boehringer reports Phase III data for nintedanib in interstitial lung disease
Clinical Trials Arena
Tue, 09/6/22 - 10:45 am
Boehringer Ingelheim
clinical trials
nintedanib
interstitial lung disease
Colorectal Cancer Treatment Market Value to Hit $9.4B by 2020
Drug Discovery and Development
Fri, 01/23/15 - 08:22 am
colorectal cancer
Avastin
Cyramza
nintedanib
Europe gives green light to AbbVie hepatitis C medicine, others
Yahoo/Reuters
Fri, 11/21/14 - 08:11 am
Europe
AbbVie
hepatitis C
dasabuvir
Sanofi
eliglustat
Novartis
secukinumab
Merck
Vorapaxar
Boehringer Ingelheim
nintedanib
Biotech Stock Mailbag: Previewing InterMune's Big Week Ahead
TheStreet.com
Fri, 05/16/14 - 10:07 am
InterMune
IPF
idiopathic pulmonary fibrosis
Boehringer Ingelheim
pirfenidone
nintedanib